Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Seppänen P[au]:

Obstetric admissions to ICUs in Finland: A multicentre study. Seppänen P et al. Intensive Crit Care Nurs. (2016)

Health-related quality of life after obstetric intensive care admission: Comparison with the general population. Seppänen PM et al. J Crit Care. (2018)

Obstetric patients' health-related quality of life before and after intensive care. Seppänen P et al. Aust Crit Care. (2018)

Search results

Items: 34

1.

Obstetric patients' health-related quality of life before and after intensive care.

Seppänen P, Sund R, Ala-Kokko T, Roos M, Uotila J, Helminen M, Suominen T.

Aust Crit Care. 2018 Mar 23. pii: S1036-7314(17)30274-6. doi: 10.1016/j.aucc.2018.02.009. [Epub ahead of print]

PMID:
29580964
2.

Health-related quality of life after obstetric intensive care admission: Comparison with the general population.

Seppänen PM, Sund RT, Ala-Kokko TI, Uotila JT, Helminen MT, Suominen TM.

J Crit Care. 2018 Feb;43:276-280. doi: 10.1016/j.jcrc.2017.09.034. Epub 2017 Sep 21.

PMID:
28965036
3.

Obstetric admissions to ICUs in Finland: A multicentre study.

Seppänen P, Sund R, Roos M, Unkila R, Meriläinen M, Helminen M, Ala-Kokko T, Suominen T.

Intensive Crit Care Nurs. 2016 Aug;35:38-44. doi: 10.1016/j.iccn.2016.03.002. Epub 2016 May 18.

PMID:
27209560
4.

Coping with the onset of cancer: coping strategies and resources of young people with cancer.

Kyngäs H, Mikkonen R, Nousiainen EM, Rytilahti M, Seppänen P, Vaattovaara R, Jämsä T.

Eur J Cancer Care (Engl). 2001 Mar;10(1):6-11.

PMID:
11827269
5.

Movement protein-derived resistance to triple gene block-containing plant viruses.

Seppänen P, Puska R, Honkanen J, Tyulkina LG, Fedorkin O, Morozov SYu, Atabekov JG.

J Gen Virol. 1997 Jun;78 ( Pt 6):1241-6.

PMID:
9191914
6.

Transgene inactivation in Petunia hybrida is influenced by the properties of the foreign gene.

Elomaa P, Helariutta Y, Griesbach RJ, Kotilainen M, Seppänen P, Teeri TH.

Mol Gen Genet. 1995 Oct 25;248(6):649-56.

PMID:
7476867
7.

Principles and background for the construction of transgenic plants displaying multiple virus resistance.

Truve E, Kelve M, Aaspôllu A, Kuusksalu A, Seppänen P, Saarma M.

Arch Virol Suppl. 1994;9:41-50. Review.

PMID:
8032271
8.

Transgenic potato plants expressing mammalian 2'-5' oligoadenylate synthetase are protected from potato virus X infection under field conditions.

Truve E, Aaspôllu A, Honkanen J, Puska R, Mehto M, Hassi A, Teeri TH, Kelve M, Seppänen P, Saarma M.

Biotechnology (N Y). 1993 Sep;11(9):1048-52.

PMID:
7764002
9.
10.

Complete amino acid sequence of human ornithine decarboxylase deduced from complementary DNA.

Hickok NJ, Seppänen PJ, Gunsalus GL, Jänne OA.

DNA. 1987 Jun;6(3):179-87.

PMID:
3595418
11.

Two ornithine decarboxylase mRNA species in mouse kidney arise from size heterogeneity at their 3' termini.

Hickok NJ, Seppänen PJ, Kontula KK, Jänne PA, Bardin CW, Jänne OA.

Proc Natl Acad Sci U S A. 1986 Feb;83(3):594-8.

12.

Human ornithine decarboxylase sequences map to chromosome regions 2pter----p23 and 7cen----qter but are not coamplified with the NMYC oncogene.

Winqvist R, Mäkelä TP, Seppänen P, Jänne OA, Alhonen-Hongisto L, Jänne J, Grzeschik KH, Alitalo K.

Cytogenet Cell Genet. 1986;42(3):133-40.

PMID:
3755388
13.

Regulation of gene expression by androgens in murine kidney.

Catterall JF, Kontula KK, Watson CS, Seppänen PJ, Funkenstein B, Melanitou E, Hickok NJ, Bardin CW, Jänne OA.

Recent Prog Horm Res. 1986;42:71-109. Review. No abstract available.

PMID:
3526457
14.

Difluoromethylornithine-induced amplification of ornithine decarboxylase genes in Ehrlich ascites carcinoma cells.

Alhonen-Hongisto L, Kallio A, Sinervirta R, Seppänen P, Kontula KK, Jänne OA, Jänne J.

Biochem Biophys Res Commun. 1985 Jan 31;126(2):734-40.

PMID:
2983688
15.

Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.

Kontula KK, Seppänen PJ, van Duyne P, Bardin CW, Jänne OA.

Endocrinology. 1985 Jan;116(1):226-33.

PMID:
3964747
16.

A rapid chemiluminescence-based method for the determination of total polyamines in biological samples.

Fagerström R, Seppänen P, Jänne J.

Clin Chim Acta. 1984 Oct 29;143(1):45-50. No abstract available.

PMID:
6499215
17.

Glyoxal bis(guanylhydrazone) as an inhibitor of polyamine biosynthesis in tumour cells.

Seppänen P, Fagerström R, Alhonen-Hongisto L, Elo H, Lumme P, Jänne J.

Biochem J. 1984 Jul 15;221(2):483-8.

18.

Inhibition of long-chain fatty acid oxidation by methylglyoxal bis(guanylhydrazone).

Nikula P, Alhonen-Hongisto L, Seppänen P, Jänne J.

Biochem Biophys Res Commun. 1984 Apr 16;120(1):9-14.

PMID:
6712703
19.

Ethylglyoxal bis(guanylhydrazone) as an inhibitor of polyamine biosynthesis in L1210 leukemia cells.

Seppänen P, Ruohola H, Jänne J.

Biochim Biophys Acta. 1984 Apr 16;803(4):331-7.

PMID:
6322861
20.

Combined use of 2-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in normal and leukemia-bearing mice.

Seppänen P, Alhonen-Hongisto L, Jänne J.

Cancer Lett. 1983 Feb;18(1):1-10.

PMID:
6402294
21.

Two enzyme inhibition assays for methylglyoxal bis(guanylhydrazone).

Seppänen P, Alhonen-Hongisto L, Käpyaho K, Jänne J.

Methods Enzymol. 1983;94:247-53. No abstract available.

PMID:
6413819
22.
23.

Methylglyoxal bis(guanylhydrazone) stimulates the cellular transport system of the polyamines.

Alhonen-Hongisto L, Seppänen P, Jänne J.

FEBS Lett. 1982 Aug 23;145(2):182-6. No abstract available.

24.

Indirect determination of methylglyoxal bis(guanylhydrazone) in leukocytes of leukemia patients.

Seppänen P, Alhonen-Hongisto L, Jänne J, Raina A, Eloranta T.

Clin Chim Acta. 1982 Aug 4;123(1-2):187-92. No abstract available.

PMID:
7116638
25.

Replacement of natural polyamines by cadaverine and its aminopropyl derivatives in Ehrlich ascites carcinoma cells.

Alhonen-Hongisto L, Seppänen P, Hölttä E, Jänne J.

Biochem Biophys Res Commun. 1982 May 31;106(2):291-7. No abstract available.

PMID:
6809002
26.

Use of polyamine antimetabolites in experimental tumours and in human leukemia.

Jänne J, Alhonen-Hongisto L, Seppänen P, Siimes M.

Med Biol. 1981 Dec;59(5-6):448-57. Review. No abstract available.

PMID:
6803081
27.

Synergistic action of two polyamine antimetabolites leads to a rapid therapeutic response in childhood leukemia.

Siimes M, Seppänen P, Alhonen-Hongisto L, Jänne J.

Int J Cancer. 1981 Nov 15;28(5):567-70.

PMID:
6796528
28.

Death of tumor cells in response to the use of a system of stimulated polyamine uptake from the transport of methylglyoxal bis(guanylhydrazone).

Seppänen P, Alhonen-Hongisto L, Jänne J.

Eur J Biochem. 1981 Sep 1;118(3):571-6. No abstract available.

29.

Polyamine deprivation-induced enhanced uptake of methylglyoxal bis(guanylhydrazone) by tumor cells.

Seppänen P, Alhonen-Hongisto L, Jänne J.

Biochim Biophys Acta. 1981 May 5;674(2):169-77.

PMID:
6786360
32.

Quantitation of methylglyoxal bis(guanylhydrazone) in blood plasma and leukemia cells of patients receiving the drug.

Seppänen P, Alhonen-Hongisto L, Siimes M, Jänne J.

Int J Cancer. 1980 Nov 15;26(5):571-6.

PMID:
6940849
33.

Relation of the antiproliferative action of methylglyoxal-bis(guanylhydrazone) to the natural polyamines.

Seppänen P, Alhonen-Hongisto L, Jänne J.

Eur J Biochem. 1980 Sep;110(1):7-12.

34.

Sensitive enzymic determination of methylglyoxal bis(guanylhydrazone) in cultured cells and in animal tissues.

Seppänen P, Alhonen-Hongisto L, Pösö H, Jänne J.

FEBS Lett. 1980 Feb 25;111(1):99-103. No abstract available.

Supplemental Content

Loading ...
Support Center